International Medication Safety Network

Home - International Medication Safety Network

Menu

Skip to content
  • Home
  • About IMSN
    • Salamanca Declaration
    • IMSN Members
    • IMSN Observers
    • How to join IMSN
    • IMSN membership benefit and privileges
    • Leadership
    • Contact IMSN
  • IMSN advocacy
    • Press releases
    • Positions & statements
      • Pharmacovigilance and Medication Errors
      • Safer Medicines Naming
      • Safer Packaging and Labelling
    • Vaccine Safety
      • 2015 Position Statement
      • 2-component vaccines – GTMSBP 4
      • Covid-19 Vaccine Safety
    • Other publications
  • Best Practices
    • GTMSBP 1 – potassium concentrate injection
    • GTMSBP 2 – vinca alkaloids in a minibag
    • GTMSBP 3 – oral methotrexate
    • GTMSBP 4 – 2-component vaccines
    • GTMSBP 5 – safe oxytocin use
  • Reporting Portal
    • Reporting Form
    • Existing NRLS
    • Your reports at work
  • Public events
    • IMSN meetings
      • 2023 IMSN Annual Meeting, Philadelphia
      • Older events
        • 17th Annual IMSN Meeting – November 14-15, 2022
        • 16th Annual IMSN Meeting – November 8-9, 2021
        • 2019 Rabat – Eastern Mediterranean Countries Workshop on Medication Errors
        • 2018 Cascais – APFH Workshop on medication safety
        • 2017 Beijing – 5th International Forum on Medication Safety
        • 2016 – Toronto – IMSN Global Regulatory Meeting
        • 2015 – Cartagena – III International ACQFH Symposium
        • 2014 Singapore 24th Pharmacy Congress
        • 2013 Paris Conference on safer naming, labelling and packaging of medicines
        • 2012 Abu Dhabi 5th Medication Safety Conference
        • 2011 Hong Kong International Medication Safety Conference
        • 2010 Ouro Preto International Forum on Patient Safety: Medication Errors
        • 2006 Madrid International Conference on patient safety
    • Medication safety curricula
      • Medication Safety: an International Experience
      • Practicum in Medication Safety for International Practitioners
      • Basic Medication Safety (BMS) Course
      • WHO Education & Training
    • International Harmonization in progress
      • FDA/IMSN Joint Global Summit on Labelling and Packaging
      • Global Meeting on Drug Product Labelling and Packaging Safety – Cascais, Portugal
  • Resources
    • IMSN members publications
    • IMSN members initiatives
    • Other resources
  • Members Only
    • Members Blog
    • IMSN annual meetings
      • 18th Annual IMSN Meeting – Philadelphia 2023
      • Past Meeting Archives
        • 17th Annual IMSN Virtual Meeting – November 14-15, 2022
        • 16th Annual IMSN Virtual Meeting – November 8-9, 2021
        • 15th Annual IMSN Virtual Meeting – October 28-29, 2020
        • 14th Annual IMSN Meeting – Rabat 2019
        • 13th Annual IMSN Meeting – Cascais 2018
        • 12th Annual IMSN Meeting – Beijing 2017
        • 11th Annual IMSN Meeting – Toronto 2016
        • 10th IMSN Annual meeting – Cartagena 2015
        • 9th IMSN Annual Meeting – Singapore – October 2014
        • 8th IMSN Annual Meeting – Paris – October 2013
        • 7th IMSN Annual Meeting – Abu Dhabi – November 2012
        • 6th IMSN Annual Meeting – Hong Kong – November 2011
        • 5th IMSN Annual Meeting – Ouro Preto – September 2010
        • 4th IMSN Annual Meeting – Copenhagen – October 2009
        • 3rd IMSN Annual Meeting – Chicago – November 2008
        • 2nd IMSN Annual Meeting – Dublin – November 2007
        • 1st IMSN Annual Meeting – Salamanca – November 2007
    • IMSN working at international level
      • WHO Global Patient Safety Challenge – Medication Safety
      • WHO INN Programme
        • Risks related to the nomenclature of antibody-drug conjugates
        • Advices welcomed on proposed INNs
      • UMC Uppsala Monitoring Centre – WHO Pharmacovigilance Programme
      • JCI Joint Commission International
      • FIP
      • ISOPP International Society of Oncology Pharmacy Practitioners
    • European IMSN branch
      • EC European Commission
      • EMA European Medicine Agency
      • WHO Europe
      • EDQM – Council of Europe
      • EAHP European Association Hospital Pharmacists
      • ESCP European Society of Clinical Pharmacists
    • Projects and collaborative work
      • Known Drug Allergies management
      • IMSN Global Targeted Medication Safety Best Practices
      • Opioïds safety issues

Other resources

  • World Health Organisation
  • Joint Commission International Joint Commission International
  • FDA, U.S. Food and Drug Administration fda_logo
  • Medication-related FDA Patient Safety videos provided in cooperation with ISMP
  • IMSN members publications
  • IMSN members initiatives
  • Other resources

Search

Copyright © 2024 International Medication Safety Network